Immunetics wins $2.8 million contract for new HIV tests

May 18, 2010

Boston-based Immunetics, Inc. chosen for National Institutes of Health contract

BOSTON, Mass.....May 18, 2010…..Immunetics, Inc. (Boston, MA) has been selected to receive a $2.8 million contract as part of the National Heart, Lung, and Blood Institute’s (NHLBI) Retrovirus Epidemiology Donor Study-II (REDS-II) project, a long term epidemiologic study of blood safety involving HIV and other  infectious and non-infectious complications of blood transfusion.   The contract will be administered by Westat, a  research organization based in Rockville, MD, which is the coordinating center  for the REDS-II project.  Under the contract, Immunetics will develop and supply a new test for HIV, which will uniquely distinguish individuals infected with HIV from those who have been immunized with experimental HIV vaccines in clinical trials.  At present, vaccination leads to a false positive result on the current generation of HIV screening tests, a problem highlighted by recent publications in medical journals.  Clinical trials for HIV vaccines have involved thousands of vaccine recipients worldwide and continue to enroll more subjects, who stand to benefit from availability of the new test.  The NHLBI initiated this project because it will provide a test which will be useful in screening blood donors in those regions of the world where HIV vaccine trials have been or are being conducted and to avoid the permanent deferral of those donors found not to be infected with HIV.  Immunetics will work with a consortium of researchers at the National Institutes of Health, the Food and Drug Administration’s Center for Biologics Evaluation and Research where the original research leading to the new test was carried out, Blood Systems Research Institute in San Francisco, and others.  The contract is valued at $9.2 million with all options exercised.

“This contract award presents a major opportunity for Immunetics and will leverage our longtime experience in the field of HIV diagnostics and assay development” said Dr. Andrew Levin, Immunetics' CEO and Scientific Director who will be the Principal Investigator on the project.  “We see a great fit between our technology and the basic scientific advances made by the research teams at CBER and NIH.  Given the vital need for an effective HIV vaccine,  the test which we will be developing could play an essential role in current and future vaccine trials.  We are particularly pleased to announce this award today, which has been designated by the NIH as National HIV Vaccine Awareness Day, and are very excited by the potential to make a significant contribution to public health in this area.”

* * * * * * *

Immunetics offers state-of-the-art assay technology for infectious disease diagnosis and pathogen detection, and for over ten years has been a leading innovator of tests for bacterial, viral and parasitic diseases. The company produces and markets a range of infectious disease assay kits and instruments.  Its mission is better, cost-efficient care through more accurate diagnosis.

 

 

 

BioFlash

Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.